Keyphrases
Colorectal Cancer
100%
Silica
100%
Mesoporous
100%
SiO2 Nanoparticles
100%
Eu Doping
100%
Theranostic Radiopharmaceuticals
100%
Lutetium-177 (177Lu)
100%
Nanoparticles
72%
Eu3+
18%
SPECT Imaging
18%
HT-29
18%
Radioactivity
18%
Nanomaterials
18%
Mouse Model
9%
Tumor Growth
9%
Disease Progression
9%
Disease Stage
9%
Effective Treatment
9%
Further Development
9%
Fluorescence Microscopy
9%
Cellular Uptake
9%
Therapeutic Potential
9%
Nanotechnology
9%
Fourier Transform Infrared Spectroscopy (FT-IR)
9%
Image Analysis
9%
SPECT-CT
9%
Luminescence
9%
Cancer Types
9%
Clinical Treatment
9%
Radiotherapy
9%
Intratumoral Injection
9%
Intratumoral Administration
9%
Tumor Localization
9%
HT-29 Xenograft
9%
Mortality Cases
9%
Radionuclides
9%
Dual-modality Probe
9%
Amino-functionalized Mesoporous Silica
9%
Coordination Complex
9%
6-dicarboxylic Acid
9%
Tumor Radiotherapy
9%
Lanthanide Ions
9%
Pyrimidine-2
9%
Pharmacology, Toxicology and Pharmaceutical Science
Silicon Dioxide
100%
Radiopharmaceutical Agent
100%
Lutetium 177
100%
Colorectal Carcinoma
100%
Nanoparticle
72%
Neoplasm
18%
Nanomaterial
18%
Mouse Model
9%
Malignant Neoplasm
9%
Tumor Growth
9%
Scanning Electron Microscopy
9%
Disease Exacerbation
9%
Tracer
9%
Fluorescence Microscopy
9%
Mesoporous Silica
9%
Lanthanide
9%
Radioisotope
9%
Coordination Compound
9%
Dicarboxylic Acid
9%
Material Science
Nanoparticle
100%
Tumor
37%
Nanostructured Material
25%
Luminescence
12%
Thermogravimetric Analysis
12%
Lanthanide Series
12%
Fluorescence Microscopy
12%
Coordination Compound
12%
Scanning Electron Microscopy
12%
Mesoporous Silica
12%
Phase Composition
12%